The clinical importance of conditioning pain modulation: A review and clinical implications

ACS Symposium Series

Volumn 1131, Issue , 2013, Pages 9-38

  Davis, Mellar P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MODULATION;

AFFERENT NEURONS; DULOXETINE; DYNAMIC TESTS; FUNCTIONAL MRI; IRRITABLE BOWEL SYNDROMES; WIDE DYNAMIC RANGE;

HEALTH;

EID: 84905495019     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2013-1131.ch003     Document Type: Conference Paper

References (268)

1. Woolf, C. J.; Ma, Q. Nociceptors-noxious stimulus detectors. Neuron 2007, 55 (3), 353-64.
2. Basbaum, A. I.; Bautista, D. M.; Scherrer, G.; Julius, D. Cellular and molecular mechanisms of pain. Cell 2009, 139 (2), 267-84.
3. Winkelmann, R. K.; Lambert, E. H.; Hayles, A. B. Congenital absence of pain. Report of a case and experimental studies. Arch.Dermatol. 1962, 85, 325-39.
4. Morris, D. Congenital Absence of Pain. Postgrad. Med. J. 1962, 38 (445), 640-1.
5. Dahan, A.; Niesters, M.; Sarton, E. Endogenous modulation of pain is visible in the brain. Clin. Neurophysiol. 2012, 123 (4), 642-3.
6. Bingel, U.; Tracey, I. Imaging CNS modulation of pain in humans. Physiology (Bethesda) 2008, 23, 371-80.
7. Grill, J. D.; Coghill, R. C. Transient analgesia evoked by noxious stimulus offset. J. Neurophysiol. 2002, 87 (4), 2205-8.
8. Pud, D.; Granovsky, Y.; Yarnitsky, D. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain 2009, 144 (1-2), 16-9.
9. Ossipov, M. H.; Dussor, G. O.; Porreca, F. Central modulation of pain. J. Clin. Invest. 2010, 120 (11), 3779-87.
10. Oluigbo, C.; Abduljalil, A.; Yang, X.; Kalnin, A.; Knopp, M. V.; Rezai, A. R. 156 Neuroimaging Biomarkers of Chronic Neuropathic Pain and its Modulation: Resting State fMRI Signals during Spinal Cord Stimulation. Neurosurgery 2012, 71 (2), E562.
11. Nickel, F. T.; Seifert, F.; Lanz, S.; Maihofner, C. Mechanisms of neuropathic pain. Eur. Neuropsychopharmacol. 2012, 22 (2), 81-91.
12. Latremoliere, A.; Woolf, C. J. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J. Pain 2009, 10 (9), 895-926.
13. Porreca, F.; Ossipov, M. H.; Gebhart, G. F. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002, 25 (6), 319-25.
14. Porreca, F.; Burgess, S. E.; Gardell, L. R.; Vanderah, T. W.; Malan, T. P., Jr.; Ossipov, M. H.; Lappi, D. A.; Lai, J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J. Neurosci. 2001, 21 (14), 5281-8.
15. Yarnitsky, D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr. Opin. Anaesthesiol. 2010, 23 (5), 611-5.
16. Yarnitsky, D.; Arendt-Nielsen, L.; Bouhassira, D.; Edwards, R. R.; Fillingim, R. B.; Granot, M.; Hansson, P.; Lautenbacher, S.; Marchand, S.; Wilder-Smith, O. Recommendations on terminology and practice of psychophysical DNIC testing. Eur. J. Pain 2010, 14 (4), 339.
17. Moont, R.; Pud, D.; Sprecher, E.; Sharvit, G.; Yarnitsky, D. "Pain inhibits pain" mechanisms: Is pain modulation simply due to distraction? Pain 2010, 150 (1), 113-20.
18. Lewis, G. N.; Heales, L.; Rice, D. A.; Rome, K.; McNair, P. J. Reliability of the conditioned pain modulation paradigm to assess endogenous inhibitory pain pathways. Pain Res. Manage. 2012, 17 (2), 98-102.
19. Svensson, P.; Hashikawa, C. H.; Casey, K. L. Site-and modality-specific modulation of experimental muscle pain in humans. Brain Res. 1999, 851 (1-2), 32-8.
20. van Wijk, G.; Veldhuijzen, D. S. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J. Pain 2010, 11 (5), 408-19.
21. Treister, R.; Eisenberg, E.; Gershon, E.; Haddad, M.; Pud, D. Factors affecting -and relationships between-different modes of endogenous pain modulation in healthy volunteers. Eur. J. Pain 2010, 14 (6), 608-14.
22. Arendt-Nielsen, L.; Sluka, K. A.; Nie, H. L. Experimental muscle pain impairs descending inhibition. Pain 2008, 140 (3), 465-71.
23. Bouhassira, D.; Chollet, R.; Coffin, B.; Lemann, M.; Le Bars, D.; Willer, J. C.; Jian, R. Inhibition of a somatic nociceptive reflex by gastric distention in humans. Gastroenterology 1994, 107 (4), 985-92.
24. Bouhassira, D.; Sabate, J. M.; Coffin, B.; Le Bars, D.; Willer, J. C.; Jian, R. Effects of rectal distensions on nociceptive flexion reflexes in humans. Am. J. Physiol. 1998, 275 (3), G410-7.
25. Granot, M.; Weissman-Fogel, I.; Crispel, Y.; Pud, D.; Granovsky, Y.; Sprecher, E.; Yarnitsky, D. Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paradigm: do conditioning stimulus painfulness, gender and personality variables matter? Pain 2008, 136 (1-2), 142-9.
26. Pud, D.; Sprecher, E.; Yarnitsky, D. Homotopic and heterotopic effects of endogenous analgesia in healthy volunteers. Neurosci. Lett. 2005, 380 (3), 209-13.
27. Roby-Brami, A.; Bussel, B.; Willer, J. C.; Le Bars, D. An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli. Probable involvement of a supraspinal loop. Brain 1987, 110 (Pt. 6), 1497-508.
28. Willer, J. C.; Roby, A.; Le Bars, D. Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain 1984, 107 (Pt. 4), 1095-112.
29. Ram, K. C.; Eisenberg, E.; Haddad, M.; Pud, D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain -new perspective of opioid-induced hyperalgesia. Pain 2008, 139 (2), 431-8.
30. Kakigi, R. Diffuse noxious inhibitory control. Reappraisal by pain-related somatosensory evoked potentials following CO2 laser stimulation. J. Neurol. Sci. 1994, 125 (2), 198-205.
31. Kosek, E.; Ordeberg, G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 2000, 88 (1), 69-78.
32. Le Bars, D.; Villanueva, L. Electrophysiological evidence for the activation of descending inhibitory controls by nociceptive afferent pathways. Prog. Brain Res. 1988, 77, 275-99.
33. Peters, M. L.; Schmidt, A. J.; Van den Hout, M. A.; Koopmans, R.; Sluijter, M. E. Chronic back pain, acute postoperative pain and the activation of diffuse noxious inhibitory controls (DNIC). Pain 1992, 50 (2), 177-87.
34. Leffler, A. S.; Kosek, E.; Lerndal, T.; Nordmark, B.; Hansson, P. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur. J. Pain 2002, 6 (2), 161-76.
35. Danziger, N.; Weil-Fugazza, J.; Le Bars, D.; Bouhassira, D. Stage-dependent changes in the modulation of spinal nociceptive neuronal activity during the course of inflammation. Eur. J. Neurosci. 2001, 13 (2), 230-40.
36. Danziger, N.; Weil-Fugazza, J.; Le Bars, D.; Bouhassira, D. Alteration of descending modulation of nociception during the course of monoarthritis in the rat. J. Neurosci. 1999, 19 (6), 2394-400.
37. Weissman-Fogel, I.; Granovsky, Y.; Crispel, Y.; Ben-Nun, A.; Best, L. A.; Yarnitsky, D.; Granot, M. Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase. J. Pain 2009, 10 (6), 628-36.
38. Staud, R.; Robinson, M. E.; Price, D. D. Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J. Pain 2007, 8 (11), 893-901.
39. Staud, R.; Cannon, R. C.; Mauderli, A. P.; Robinson, M. E.; Price, D. D.; Vierck, C. J., Jr. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003, 102 (1-2), 87-95.
40. Price, D. D.; Staud, R.; Robinson, M. E.; Mauderli, A. P.; Cannon, R.; Vierck, C. J. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002, 99 (1-2), 49-59.
41. Staud, R.; Vierck, C. J.; Cannon, R. L.; Mauderli, A. P.; Price, D. D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001, 91 (1-2), 165-75.
42. Potvin, S.; Paul-Savoie, E.; Morin, M.; Bourgault, P.; Marchand, S. Temporal summation of pain is not amplified in a large proportion of fibromyalgia patients. Pain Res. Treat. 2012, 2012, 938595.
43. Yarnitsky, D.; Granot, M.; Nahman-Averbuch, H.; Khamaisi, M.; Granovsky, Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012, 153 (6), 1193-8.
44. Serrao, M.; Rossi, P.; Sandrini, G.; Parisi, L.; Amabile, G. A.; Nappi, G.; Pierelli, F. Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain 2004, 112 (3), 353-60.
45. Edwards, R. R.; Ness, T. J.; Weigent, D. A.; Fillingim, R. B. Individual differences in diffuse noxious inhibitory controls (DNIC): Association with clinical variables. Pain 2003, 106 (3), 427-37.
46. Lautenbacher, S.; Prager, M.; Rollman, G. B. Pain additivity, diffuse noxious inhibitory controls, and attention: A functional measurement analysis. Somatosens. Mot. Res. 2007, 24 (4), 189-201.
47. Moont, R.; Crispel, Y.; Lev, R.; Pud, D.; Yarnitsky, D. Temporal changes in cortical activation during distraction from pain: A comparative LORETA study with conditioned pain modulation. Brain Res. 2012, 1435, 105-17.
48. Lautenbacher, S.; Kundermann, B.; Krieg, J. C. Sleep deprivation and pain perception. Sleep Med. Rev. 2006, 10 (5), 357-69.
49. Smith, M. T.; Haythornthwaite, J. A. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med. Rev. 2004, 8 (2), 119-32.
50. Edwards, R. R.; Grace, E.; Peterson, S.; Klick, B.; Haythornthwaite, J. A.; Smith, M. T. Sleep continuity and architecture: Associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur. J. Pain 2009, 13 (10), 1043-7.
51. Haack, M.; Scott-Sutherland, J.; Santangelo, G.; Simpson, N. S.; Sethna, N.; Mullington, J. M. Pain sensitivity and modulation in primary insomnia. Eur. J. Pain 2012, 16 (4), 522-33.
52. Goffaux, P.; Redmond, W. J.; Rainville, P.; Marchand, S. Descending analgesia-when the spine echoes what the brain expects. Pain 2007, 130 (1-2), 137-43.
53. Goffaux, P.; de Souza, J. B.; Potvin, S.; Marchand, S. Pain relief through expectation supersedes descending inhibitory deficits in fibromyalgia patients. Pain 2009, 145 (1-2), 18-23.
54. Sullivan, M. J.; Rodgers, W. M.; Kirsch, I. Catastrophizing, depression and expectancies for pain and emotional distress. Pain 2001, 91 (1-2), 147-54.
55. Weissman-Fogel, I.; Sprecher, E.; Pud, D. Effects of catastrophizing on pain perception and pain modulation. Exp. Brain Res. 2008, 186 (1), 79-85.
56. Goodin, B. R.; McGuire, L.; Allshouse, M.; Stapleton, L.; Haythornthwaite, J. A.; Burns, N.; Mayes, L. A.; Edwards, R. R. Associations between catastrophizing and endogenous pain-inhibitory processes: sex differences. J. Pain 2009, 10 (2), 180-90.
57. King, C. D.; Goodin, B.; Kindler, L. L.; Caudle, R. M.; Edwards, R. R.; Gravenstein, N.; Riley, J. L., III; Fillingim, R. B. Reduction of conditioned pain modulation in humans by naltrexone: An exploratory study of the effects of pain catastrophizing. J. Behav. Med. 2012.
58. Campbell, C. M.; France, C. R.; Robinson, M. E.; Logan, H. L.; Geffken, G. R.; Fillingim, R. B. Ethnic differences in diffuse noxious inhibitory controls. J. Pain 2008, 9 (8), 759-66.
59. Edwards, C. L.; Fillingim, R. B.; Keefe, F. Race, ethnicity and pain. Pain 2001, 94 (2), 133-7.
60. Mechlin, M. B.; Maixner, W.; Light, K. C.; Fisher, J. M.; Girdler, S. S. African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures. Psychosom. Med. 2005, 67 (6), 948-56.
61. Rahim-Williams, F. B.; Riley, J. L., 3rd; Herrera, D.; Campbell, C. M.; Hastie, B. A.; Fillingim, R. B. Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics. Pain 2007, 129 (1-2), 177-84.
62. Gagliese, L.; Melzack, R. Chronic pain in elderly people. Pain 1997, 70 (1), 3-14.
63. Brattberg, G.; Parker, M. G.; Thorslund, M. A longitudinal study of pain: reported pain from middle age to old age. Clin. J. Pain 1997, 13 (2), 144-9.
64. Washington, L. L.; Gibson, S. J.; Helme, R. D. Age-related differences in the endogenous analgesic response to repeated cold water immersion in human volunteers. Pain 2000, 89 (1), 89-96.
65. Edwards, R. R.; Fillingim, R. B.; Ness, T. J. Age-related differences in endogenous pain modulation: A comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 2003, 101 (1-2), 155-65.
66. Lariviere, M.; Goffaux, P.; Marchand, S.; Julien, N. Changes in pain perception and descending inhibitory controls start at middle age in healthy adults. Clin. J. Pain 2007, 23 (6), 506-10.
67. Riley, J. L., 3rd; King, C. D.; Wong, F.; Fillingim, R. B.; Mauderli, A. P. Lack of endogenous modulation and reduced decay of prolonged heat pain in older adults. Pain 2010, 150 (1), 153-60.
68. Tousignant-Laflamme, Y.; Marchand, S. Excitatory and inhibitory pain mechanisms during the menstrual cycle in healthy women. Pain 2009, 146 (1-2), 47-55.
69. Bartley, E. J.; Rhudy, J. L. Endogenous inhibition of the nociceptive flexion reflex (NFR) and pain ratings during the menstrual cycle in healthy women. Ann. Behav. Med. 2012, 43 (3), 343-51.
70. Rezaii, T.; Hirschberg, A. L.; Carlstrom, K.; Ernberg, M. The influence of menstrual phases on pain modulation in healthy women. J. Pain 2012, 13 (7), 646-55.
71. Rezaii, T.; Ernberg, M. Influence of oral contraceptives on endogenous pain control in healthy women. Exp. Brain Res. 2010, 203 (2), 329-38.
72. Staud, R.; Robinson, M. E.; Vierck, C. J., Jr.; Price, D. D. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003, 101 (1-2), 167-74.
73. Baad-Hansen, L.; Poulsen, H. F.; Jensen, H. M.; Svensson, P. Lack of sex differences in modulation of experimental intraoral pain by diffuse noxious inhibitory controls (DNIC). Pain 2005, 116 (3), 359-65.
74. France, C. R.; Suchowiecki, S. A comparison of diffuse noxious inhibitory controls in men and women. Pain 1999, 81 (1-2), 77-84.
75. Tousignant-Laflamme, Y.; Page, S.; Goffaux, P.; Marchand, S. An experimental model to measure excitatory and inhibitory pain mechanisms in humans. Brain Res. 2008, 1230, 73-9.
76. Oono, Y.; Wang, K.; Svesson, P.; Arendt-Nielsen, L. Conditioned pain modulation evoked by different intensities of mechanical stimuli applied to the craniofacial region in healthy men and women. J. Orofac. Pain. 2011, 25 (4), 364-75.
77. Julien, N.; Goffaux, P.; Arsenault, P.; Marchand, S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005, 114 (1-2), 295-302.
78. Pielsticker, A.; Haag, G.; Zaudig, M.; Lautenbacher, S. Impairment of pain inhibition in chronic tension-type headache. Pain 2005, 118 (1-2), 215-23.
79. Wilder-Smith, C. H.; Schindler, D.; Lovblad, K.; Redmond, S. M.; Nirkko, A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004, 53 (11), 1595-601.
80. Berkley, K. J. Sex differences in pain. Behav. Brain Sci. 1997, 20 (3), 371-80, 435-513 (discussion).
81. Mayer, E. A.; Naliboff, B.; Lee, O.; Munakata, J.; Chang, L. Review article: gender-related differences in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 1999, 13 (Suppl. 2), 65-9.
82. Landau, R.; Kraft, J. C.; Flint, L. Y.; Carvalho, B.; Richebe, P.; Cardoso, M.; Lavand'homme, P.; Granot, M.; Yarnitsky, D.; Cahana, A. An experimental paradigm for the prediction of Post-Operative Pain (PPOP). J. Visualized Exp. 2010 (35), 1671.
83. Yarnitsky, D.; Crispel, Y.; Eisenberg, E.; Granovsky, Y.; Ben-Nun, A.; Sprecher, E.; Best, L.-A.; Granot, M. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain 2008, 138 (1), 22-8.
84. Veves, A.; Young, M. J.; Manes, C.; Boulton, A. J. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994, 17 (10), 1200-2.
85. Bouhassira, D.; Attal, N.; Willer, J. C.; Brasseur, L. Painful and painless peripheral sensory neuropathies due to HIV infection: A comparison using quantitative sensory evaluation. Pain 1999, 80 (1-2), 265-72.
86. Sorensen, L.; Molyneaux, L.; Yue, D. K. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006, 29 (4), 883-7.
87. Kramer, H. H.; Rolke, R.; Bickel, A.; Birklein, F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 2004, 27 (10), 2386-91.
88. Nahman-Averbuch, H.; Yarnitsky, D.; Granovsky, Y.; Sprecher, E.; Steiner, M.; Tzuk-Shina, T.; Pur, D. Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy. J. Pain Symptom Manage. 2011, 42 (2), 229-38.
89. Arendt-Nielsen, L.; Frokjaer, J. B.; Staahl, C.; Graven-Nielsen, T.; Huggins, J. P.; Smart, T. S.; Drewes, A. M. Effects of gabapentin on experimental somatic pain and temporal summation. Reg. Anesth. Pain Med. 2007, 32 (5), 382-8.
90. Yucel, A.; Ozyalcin, S.; Koknel Talu, G.; Kiziltan, E.; Yucel, B.; Andersen, O. K.; Arendt-Lielsen, L.; Disci, R. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: A double blind, placebo controlled study. Eur. J. Pain 2005, 9 (4), 407-16.
91. Bouhassira, D.; Danziger, N.; Attal, N.; Guirimand, F. Comparison of the pain suppressive effects of clinical and experimental painful conditioning stimuli. Brain 2003, 126 (Pt. 5), 1068-78.
92. Danziger, N.; Gautron, M.; Le Bars, D.; Bouhassira, D. Activation of diffuse noxious inhibitory controls (DNIC) in rats with an experimental peripheral mononeuropathy. Pain 2001, 91 (3), 287-96.
93. Craig, A. D. Pain mechanisms: labeled lines versus convergence in central processing. Annu. Rev. Neurosci. 2003, 26, 1-30.
94. von Hehn, C. A.; Baron, R.; Woolf, C. J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012, 73 (4), 638-52.
95. Paemeleire, K.; Van Buyten, J. P.; Van Buynder, M.; Alicino, D.; Van Maele, G.; Smet, I.; Goadsby, P. J. Phenotype of patients responsive to occipital nerve stimulation for refractory head pain. Cephalalgia 2010, 30 (6), 662-73.
96. De Broucker, T.; Cesaro, P.; Willer, J. C.; Le Bars, D. Diffuse noxious inhibitory controls in man. Involvement of the spinoreticular tract. Brain 1990, 113 (Pt. 4), 1223-34.
97. MacGowan, D. J.; Janal, M. N.; Clark, W. C.; Wharton, R. N.; Lazar, R. M.; Sacco, R. L.; Mohr, J. P. Central poststroke pain and Wallenbergs lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology 1997, 49 (1), 120-5.
98. Bezov, D.; Ashina, S.; Jensen, R.; Bendtsen, L. Pain perception studies in tension-type headache. Headache 2011, 51 (2), 262-71.
99. Mylius, V.; Engau, I.; Teepker, M.; Stiasny-Kolster, K.; Schepelmann, K.; Oertel, W. H.; Lautenbacher, S.; Möller, J. C. Pain sensitivity and descending inhibition of pain in Parkinsons disease. J. Neurol., Neurosurg. Psychiatry 2009, 80 (1), 24-8.
100. Potvin, S.; Stip, E.; Tempier, A.; Pampoulova, T.; Bentaleb, L. A.; Lalonde, P.; Lipp, O.; Goffaux, P.; Marchand, S. Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. J. Psychiatr. Res. 2008, 42 (12), 1010-6.
101. de Tommaso, M.; Valeriani, M.; Guido, M.; Libro, G.; Specchio, L. M.; Tonali, P.; Puca, F. Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain 2003, 101 (1-2), 25-32.
102. Kosek, E.; Hansson, P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997, 70 (1), 41-51.
103. Lautenbacher, S.; Rollman, G. B. Possible deficiencies of pain modulation in fibromyalgia. Clin. J. Pain 1997, 13 (3), 189-96.
104. Bragdon, E. E.; Light, K. C.; Costello, N. L.; Sigurdsson, A.; Bunting, S.; Bhalang, K.; Maixner, W. Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain 2002, 96 (3), 227-37.
105. Sandrini, G.; Rossi, P.; Milanov, I.; Serrao, M.; Cecchini, A. P.; Nappi, G. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 2006, 26 (7), 782-9.
106. King, C. D.; Wong, F.; Currie, T.; Mauderli, A. P.; Fillingim, R. B.; Riley, J. L., 3rd. Deficiency in endogenous modulation of prolonged heat pain in patients with Irritable Bowel Syndrome and Temporomandibular Disorder. Pain 2009, 143 (3), 172-8.
107. Piche, M.; Bouin, M.; Arsenault, M.; Poitras, P.; Rainville, P. Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience 2011, 195, 166-75.
108. Song, G. H.; Venkatraman, V.; Ho, K. Y.; Chee, M. W.; Yeoh, K. G.; Wilder-Smith, C. H. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain 2006, 126 (1-3), 79-90.
109. Chalaye, P.; Goffaux, P.; Bourgault, P.; Lafrenaye, S.; Devroede, G.; Watier, A.; Marchand, S. Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin. J. Pain 2012, 28 (6), 519-26.
110. Staud, R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev. Neurother. 2012, 12 (5), 577-85.
111. Meeus, M.; Nijs, J.; Van de Wauwer, N.; Toeback, L.; Truijen, S. Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: An experimental study. Pain 2008, 139 (2), 439-48.
112. de Souza, J. B.; Potvin, S.; Goffaux, P.; Charest, J.; Marchand, S. The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin. J. Pain 2009, 25 (2), 123-7.
113. Leonard, G.; Goffaux, P.; Mathieu, D.; Blanchard, J.; Kenny, B.; Marchand, S. Evidence of descending inhibition deficits in atypical but not classical trigeminal neuralgia. Pain 2009, 147 (1-3), 217-23.
114. Buchgreitz, L.; Egsgaard, L. L.; Jensen, R.; Arendt-Nielsen, L.; Bendtsen, L. Abnormal pain processing in chronic tension-type headache: A high-density EEG brain mapping study. Brain 2008, 131 (Pt. 12), 3232-8.
115. Cathcart, S.; Winefield, A. H.; Lushington, K.; Rolan, P. Noxious inhibition of temporal summation is impaired in chronic tension-type headache. Headache 2010, 50 (3), 403-12.
116. Okada-Ogawa, A.; Porreca, F.; Meng, I. D. Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons. J. Neurosci. 2009, 29 (50), 15828-35.
117. Sultan, A.; Gaskell, H.; Derry, S.; Moore, R. A. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol. 2008, 8, 29.
118. Gomersall, J. D.; Stuart, A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J. Neurol., Neurosurg. Psychiatry 1973, 36 (4), 684-90.
119. Bendtsen, L. Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 2000, 20 (5), 486-508.
120. Nir, R. R.; Yarnitsky, D.; Honigman, L.; Granot, M. Cognitive manipulation targeted at decreasing the conditioning pain perception reduces the efficacy of conditioned pain modulation. Pain 2012, 153 (1), 170-6.
121. Bouhassira, D.; Villanueva, L.; Bing, Z.; le Bars, D. Involvement of the subnucleus reticularis dorsalis in diffuse noxious inhibitory controls in the rat. Brain Res. 1992, 595 (2), 353-7.
122. Le Bars, D. The whole body receptive field of dorsal horn multireceptive neurones. Brain Res. Rev. 2002, 40 (1-3), 29-44.
123. Le Bars, D.; Dickenson, A. H.; Besson, J. M. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain 1979, 6 (3), 305-27.
124. Gall, O.; Bouhassira, D.; Chitour, D.; Le Bars, D. Involvement of the caudal medulla in negative feedback mechanisms triggered by spatial summation of nociceptive inputs. J. Neurophysiol. 1998, 79 (1), 304-11.
125. Lapirot, O.; Chebbi, R.; Monconduit, L.; Artola, A.; Dallel, R.; Luccarini, P. NK1 receptor-expressing spinoparabrachial neurons trigger diffuse noxious inhibitory controls through lateral parabrachial activation in the male rat. Pain 2009, 142 (3), 245-54.
126. Villanueva, L.; Le Bars, D. The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol. Res. 1995, 28 (1), 113-25.
127. Le Bars, D.; Villanueva, L.; Bouhassira, D.; Willer, J. C. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol. Fiziol. Eksp. Ter. 1992 (4), 55-65.
128. Cadden, S. W.; Villanueva, L.; Chitour, D.; Le Bars, D. Depression of activities of dorsal horn convergent neurones by propriospinal mechanisms triggered by noxious inputs; comparison with diffuse noxious inhibitory controls (DNIC). Brain Res. 1983, 275 (1), 1-11.
129. Hu, J. W. Response properties of nociceptive and non-nociceptive neurons in the rats trigeminal subnucleus caudalis (medullary dorsal horn) related to cutaneous and deep craniofacial afferent stimulation and modulation by diffuse noxious inhibitory controls. Pain 1990, 41 (3), 331-45.
130. Schouenborg, J.; Dickenson, A. Effects of a distant noxious stimulation on A and C fibre-evoked flexion reflexes and neuronal activity in the dorsal horn of the rat. Brain Res. 1985, 328 (1), 23-32.
131. Cook, A. J.; Woolf, C. J.; Wall, P. D.; McMahon, S. B. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987, 325 (7000), 151-3.
132. Woolf, C. J.; King, A. E. Physiology and morphology of multireceptive neurons with C-afferent fiber inputs in the deep dorsal horn of the rat lumbar spinal cord. J. Neurophysiol. 1987, 58 (3), 460-79.
133. Dickenson, A. H.; Le Bars, D. Diffuse noxious inhibitory controls (DNIC) involve trigeminothalamic and spinothalamic neurones in the rat. Exp. Brain Res. 1983, 49 (2), 174-80.
134. Le Bars, D.; Dickenson, A. H.; Besson, J. M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 1979, 6 (3), 283-304.
135. Villanueva, L.; Cadden, S. W.; Le Bars, D. Diffuse noxious inhibitory controls (DNIC): evidence for post-synaptic inhibition of trigeminal nucleus caudalis convergent neurones. Brain Res. 1984, 321 (1), 165-8.
136. Williams, S.; Evan, G. I.; Hunt, S. P. Changing patterns of c-fos induction in spinal neurons following thermal cutaneous stimulation in the rat. Neuroscience 1990, 36 (1), 73-81.
137. Morgan, M. M.; Gogas, K. R.; Basbaum, A. I. Diffuse noxious inhibitory controls reduce the expression of noxious stimulus-evoked Fos-like immunoreactivity in the superficial and deep laminae of the rat spinal cord. Pain 1994, 56 (3), 347-52.
138. Sandkuhler, J.; Fu, Q. G.; Zimmermann, M. Spinal pathways mediating tonic or stimulation-produced descending inhibition from the periaqueductal gray or nucleus raphe magnus are separate in the cat. J. Neurophysiol. 1987, 58 (2), 327-41.
139. Villanueva, L.; Peschanski, M.; Calvino, B.; Le Bars, D. Ascending pathways in the spinal cord involved in triggering of diffuse noxious inhibitory controls in the rat. J. Neurophysiol. 1986, 55 (1), 34-55.
140. Meng, I. D.; Hu, J. W.; Benetti, A. P.; Bereiter, D. A. Encoding of corneal input in two distinct regions of the spinal trigeminal nucleus in the rat: cutaneous receptive field properties, responses to thermal and chemical stimulation, modulation by diffuse noxious inhibitory controls, and projections to the parabrachial area. J. Neurophysiol. 1997, 77 (1), 43-56.
141. Villanueva, L.; Bouhassira, D.; Bing, Z.; Le Bars, D. Convergence of heterotopic nociceptive information onto subnucleus reticularis dorsalis neurons in the rat medulla. J. Neurophysiol. 1988, 60 (3), 980-1009.
142. Villanueva, L.; Bing, Z.; Bouhassira, D.; Le Bars, D. Encoding of electrical, thermal, and mechanical noxious stimuli by subnucleus reticularis dorsalis neurons in the rat medulla. J. Neurophysiol. 1989, 61 (2), 391-402.
143. Bernard, J. F.; Villanueva, L.; Carroue, J.; Le Bars, D. Efferent projections from the subnucleus reticularis dorsalis (SRD): A Phaseolus vulgaris leucoagglutinin study in the rat. Neurosci. Lett. 1990, 116 (3), 257-62.
144. Villanueva, L.; Bouhassira, D.; Le Bars, D. The medullary subnucleus reticularis dorsalis (SRD) as a key link in both the transmission and modulation of pain signals. Pain 1996, 67 (2-3), 231-40.
145. Bouhassira, D.; Bing, Z.; Le Bars, D. Studies of the brain structures involved in diffuse noxious inhibitory controls: the mesencephalon. J. Neurophysiol. 1990, 64 (6), 1712-23.
146. Bouhassira, D.; Bing, Z.; Le Bars, D. Studies of brain structures involved in diffuse noxious inhibitory controls in the rat: the rostral ventromedial medulla. J. Physiol. 1993, 463, 667-87.
147. Bouhassira, D.; Bing, Z.; Le Bars, D. Effects of lesions of locus coeruleus/subcoeruleus on diffuse noxious inhibitory controls in the rat. Brain Res. 1992, 571 (1), 140-4.
148. Fauvergue, X.; Lo Genco, A.; Lo Pinto, M. Virgins in the wild: mating status affects the behavior of a parasitoid foraging in the field. Oecologia 2008, 156 (4), 913-20.
149. Pinto, M.; Castro, A. R.; Tshudy, F.; Wilson, S. P.; Lima, D.; Tavares, I. Opioids modulate pain facilitation from the dorsal reticular nucleus. Mol. Cell. Neurosci. 2008, 39 (4), 508-18.
150. de Resende, M. A.; Silva, L. F.; Sato, K.; Arendt-Nielsen, L.; Sluka, K. A. Blockade of opioid receptors in the medullary reticularis nucleus dorsalis, but not the rostral ventromedial medulla, prevents analgesia produced by diffuse noxious inhibitory control in rats with muscle inflammation. J. Pain 2011, 12 (6), 687-97.
151. Bing, Z.; Villanueva, L.; Le Bars, D. Effects of systemic morphine upon A delta-and C-fibre evoked activities of subnucleus reticularis dorsalis neurones in the rat medulla. Eur. J. Pharmacol. 1989, 164 (1), 85-92.
152. Hernandez, N.; Dmitrieva, N.; Vanegas, H. Medullary on-cell activity during tail-flick inhibition produced by heterotopic noxious stimulation. Pain 1994, 58 (3), 393-401.
153. Bouhassira, D.; Villanueva, L.; Le Bars, D. Effects of systemic morphine on diffuse noxious inhibitory controls: role of the periaqueductal grey. Eur. J. Pharmacol. 1992, 216 (2), 149-56.
154. Bouhassira, D.; Chitour, D.; Villanueva, L.; Le Bars, D. Morphine and diffuse noxious inhibitory controls in the rat: effects of lesions of the rostral ventromedial medulla. Eur. J. Pharmacol. 1993, 232 (2-3), 207-15.
155. Bouhassira, D.; Chitour, D.; Villaneuva, L.; Le Bars, D. The spinal transmission of nociceptive information: modulation by the caudal medulla. Neuroscience 1995, 69 (3), 931-8.
156. Willer, J. C.; Le Bars, D.; De Broucker, T. Diffuse noxious inhibitory controls in man: involvement of an opioidergic link. Eur. J. Pharmacol. 1990, 182 (2), 347-55.
157. Dickenson, A. H.; Le Bars, D. Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat. J. Physiol. 1987, 384, 81-107.
158. Dickenson, A. H.; Le Bars, D. Morphine microinjections into periaqueductal grey matter of the rat: effects on dorsal horn neuronal responses to C-fibre activity and diffuse noxious inhibitory controls. Life Sci. 1983, 33 (Suppl. 1), 549-52.
159. Bouhassira, D.; Villanueva, L.; Le Bars, D. Intracerebroventricular morphine decreases descending inhibitions acting on lumbar dorsal horn neuronal activities related to pain in the rat. J. Pharmacol. Exp. Ther. 1988, 247 (1), 332-42.
160. Desbois, C.; Le Bars, D.; Villanueva, L. Organization of cortical projections to the medullary subnucleus reticularis dorsalis: A retrograde and anterograde tracing study in the rat. J. Comp. Neurol. 1999, 410 (2), 178-96.
161. Zhang, L.; Zhang, Y.; Zhao, Z. Q. Anterior cingulate cortex contributes to the descending facilitatory modulation of pain via dorsal reticular nucleus. Eur. J. Neurosci. 2005, 22 (5), 1141-8.
162. Bromm, B. The involvement of the posterior cingulate gyrus in phasic pain processing of humans. Neurosci. Lett. 2004, 361 (1-3), 245-9.
163. Egsgaard, L. L.; Buchgreitz, L.; Wang, L.; Bendtsen, L.; Jensen, R.; Arendt-Nielsen, L. Short-term cortical plasticity induced by conditioning pain modulation. Exp. Brain Res. 2012, 216 (1), 91-101.
164. Brock, C.; Olesen, S. S.; Valeriani, M.; Arendt-Nielsen, L.; Drewes, A. M. Brain activity in rectosigmoid pain: unravelling conditioning pain modulatory pathways. Clin. Neurophysiol. 2012, 123 (4), 829-37.
165. Watanabe, I.; Svensson, P.; Arendt-Nielsen, L. Influence of segmental and extra-segmental conditioning, stimuli on cortical potentials evoked by painful electrical stimulation. Somatosens. Mot. Res. 1999, 16 (3), 243-50.
166. Becker, S.; Gandhi, W.; Schweinhardt, P. Cerebral interactions of pain and reward and their relevance for chronic pain. Neurosci. Lett. 2012, 520 (2), 182-7.
167. Quante, M.; Hille, S.; Schofer, M. D.; Lorenz, J.; Hauck, M. Noxious counterirritation in patients with advanced osteoarthritis of the knee reduces MCC but not SII pain generators: A combined use of MEG and EEG. J. Pain Res. 2008, 1, 1-8.
168. Valeriani, M.; Tonali, P.; Le Pera, D.; Restuccia, D.; De Armas, L.; Del Vesco, C.; Miliucci, R.; Fiaschi, A.; Vigevano, F.; Arendt-Nielsen, L.; Tinazzi, M. Modulation of laser-evoked potentials by experimental cutaneous tonic pain. Neuroscience 2006, 140 (4), 1301-10.
169. Bromm, B. Brain images of pain. News Physiol. Sci. 2001, 16, 244-9.
170. Leavens, M. E.; Hill, C. S., Jr.; Cech, D. A.; Weyland, J. B.; Weston, J. S. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J. Neurosurg. 1982, 56 (2), 241-5.
171. Lazorthes, Y.; Verdie, J. C.; Bastide, R.; Lavados, A.; Descouens, D. Spinal versus intraventricular chronic opiate administration with implantable drug delivery devices for cancer pain. Appl. Neurophysiol. 1985, 48 (1-6), 234-41.
172. Lobato, R. D.; Madrid, J. L.; Fatela, L. V.; Rivas, J. J.; Reig, E.; Lamas, E. Intraventricular morphine for control of pain in terminal cancer patients. J. Neurosurg. 1983, 59 (4), 627-33.
173. Karavelis, A.; Foroglou, G.; Selviaridis, P.; Fountzilas, G. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. Neurosurgery 1996, 39 (1), 57-61discussion -2.
174. Tortorici, V.; Morgan, M. M.; Vanegas, H. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off-and on-cells in the rostral ventromedial medulla of rats. Pain 2001, 89 (2-3), 237-44.
175. Akil, H.; Mayer, D. J.; Liebeskind, J. C. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 1976, 191 (4230), 961-2.
176. Rivot, J. P.; Chaouch, A.; Besson, J. M. The influence of naloxone on the C fiber response of dorsal horn neurons and their inhibitory control by raphe magnus stimulation. Brain Res. 1979, 176 (2), 355-64.
177. Basbaum, A. I.; Fields, H. L. Endogenous pain control mechanisms: review and hypothesis. Ann. Neurol. 1978, 4 (5), 451-62.
178. Fields, H. L.; Basbaum, A. I. Brainstem control of spinal pain-transmission neurons. Annu Rev Physiol 1978, 40, 217-48.
179. Mayer, D. J.; Price, D. D. Central nervous system mechanisms of analgesia. Pain 1976, 2 (4), 379-404.
180. Celerier, E.; Rivat, C.; Jun, Y.; Laulin, J. P.; Larcher, A.; Reynier, P.; Simonnet, G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000, 92 (2), 465-72.
181. Celerier, E.; Laulin, J. P.; Corcuff, J. B.; Le Moal, M.; Simonnet, G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. J. Neurosci. 2001, 21 (11), 4074-80.
182. Mao, J.; Price, D. D.; Mayer, D. J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 1994, 14 (4), 2301-12.
183. Chu, L. F.; Angst, M. S.; Clark, D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin. J. Pain 2008, 24 (6), 479-96.
184. Chia, Y. Y.; Liu, K.; Wang, J. J.; Kuo, M. C.; Ho, S. T. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can. J. Anaesth. 1999, 46 (9), 872-7.
185. Compton, P.; Charuvastra, V. C.; Ling, W. Pain intolerance in opioidmaintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001, 63 (2), 139-46.
186. Pud, D.; Cohen, D.; Lawental, E.; Eisenberg, E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend. 2006, 82 (3), 218-23.
187. Chu, L. F.; DArcy, N.; Brady, C.; Zamora, A. K.; Young, C. A.; Kim, J. E.; Clemenson, A. M.; Angst, M. S.; Clark, J. D. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. Pain 2012, 153 (8), 1583-92.
188. Doverty, M.; White, J. M.; Somogyi, A. A.; Bochner, F.; Ali, R.; Ling, W. Hyperalgesic responses in methadone maintenance patients. Pain 2001, 90 (1-2), 91-6.
189. Chang, G.; Chen, L.; Mao, J. Opioid tolerance and hyperalgesia. Med. Clin. North Am. 2007, 91 (2), 199-211.
190. Vanderah, T. W.; Ossipov, M. H.; Lai, J.; Malan, T. P., Jr.; Porreca, F. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 2001, 92 (1-2), 5-9.
191. Wang, Z.; Gardell, L. R.; Ossipov, M. H.; Vanderah, T. W.; Brennan, M. B.; Hochgeschwender, U.; Hruby, V. J.; Malan, T. P., Jr.; Lai, J.; Porreca, F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 2001, 21 (5), 1779-86.
192. Vanderah, T. W.; Suenaga, N. M.; Ossipov, M. H.; Malan, T. P., Jr.; Lai, J.; Porreca, F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 2001, 21 (1), 279-86.
193. Gardell, L. R.; Wang, R.; Burgess, S. E.; Ossipov, M. H.; Vanderah, T. W.; Malan, T. P., Jr.; Lai, J.; Porreca, F. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J. Neurosci. 2002, 22 (15), 6747-55.
194. Gardell, L. R.; Burgess, S. E.; Dogrul, A.; Ossipov, M. H.; Malan, T. P.; Lai, J.; Porreca, F. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance. Pain 2002, 98 (1-2), 79-88.
195. Burgess, S. E.; Gardell, L. R.; Ossipov, M. H.; Malan, T. P., Jr.; Vanderah, T. W.; Lai, J.; Porreca, F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 2002, 22 (12), 5129-36.
196. Pinto, M.; Sousa, M.; Lima, D.; Tavares, I. Participation of mu-opioid, GABA(B), and NK1 receptors of major pain control medullary areas in pathways targeting the rat spinal cord: implications for descending modulation of nociceptive transmission. J. Comp. Neurol. 2008, 510 (2), 175-87.
197. Wang, X. M.; Yan, J. Q.; Zhang, K. M.; Mokha, S. S. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat. Brain Res. 1996, 739 (1-2), 235-43.
198. Gutstein, H. B.; Mansour, A.; Watson, S. J.; Akil, H.; Fields, H. L. Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla. Neuroreport 1998, 9 (8), 1777-81.
199. Pinto, M.; Lima, D.; Castro-Lopes, J.; Tavares, I. Noxious-evoked c-fos expression in brainstem neurons immunoreactive for GABAB, mu-opioid and NK-1 receptors. Eur. J. Neurosci. 2003, 17 (7), 1393-402.
200. Anderson, S. D.; Basbaum, A. I.; Fields, H. L. Response of medullary raphe neurons to peripheral stimulation and to systemic opiates. Brain Res. 1977, 123 (2), 363-8.
201. Bie, B.; Pan, Z. Z. Trafficking of central opioid receptors and descending pain inhibition. Mol. Pain 2007, 3, 37.
202. Le Bars, D.; Willer, J. C.; De Broucker, T. Morphine blocks descending pain inhibitory controls in humans. Pain 1992, 48 (1), 13-20.
203. Le Bars, D.; Chitour, D.; Kraus, E.; Clot, A. M.; Dickenson, A. H.; Besson, J. M. The effect of systemic morphine upon diffuse noxious inhibitory controls (DNIC) in the rat: evidence for a lifting of certain descending inhibitory controls of dorsal horn convergent neurones. Brain Res. 1981, 215 (1-2), 257-74.
204. Chitour, D.; Dickenson, A. H.; Le Bars, D. Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Res. 1982, 236 (2), 329-37.
205. Le Bars, D.; Rivot, J. P.; Dickenson, A. H.; Chaouch, A.; Besson, J. M. Role of serotonin in the diffuse inhibitory controls induced by nociceptive stimulation. C. R. Seances Acad. Sci., Ser. D 1980, 290 (4), 379-82.
206. Dickenson, A. H.; Rivot, J. P.; Chaouch, A.; Besson, J. M.; Le Bars, D. Diffuse noxious inhibitory controls (DNIC) in the rat with or without pCPA pretreatment. Brain Res. 1981, 216 (2), 313-21.
207. Le Bars, D.; Rivot, J. P.; Guilbaud, G.; Menetrey, D.; Besson, J. M. The depressive effects of morphine on the C fibre response of dorsal horn neurones in the spinal rat pretreated or not by pCPA. Brain Res. 1979, 176 (2), 337-53.
208. Villanueva, L.; Chitour, D.; Le Bars, D. Involvement of the dorsolateral funiculus in the descending spinal projections responsible for diffuse noxious inhibitory controls in the rat. J. Neurophysiol. 1986, 56 (4), 1185-95.
209. Robbins, A.; Schmitt, D.; Winterson, B. J.; Meng, I. D. Chronic morphine increases Fos-positive neurons after concurrent cornea and tail stimulation. Headache 2012, 52 (2), 262-73.
210. Le Bars, D.; Chitour, D.; Kraus, E.; Dickenson, A. H.; Besson, J. M. Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat. Brain Res. 1981, 204 (2), 387-402.
211. Eisenberg, E.; Midbari, A.; Haddad, M.; Pud, D. Predicting the analgesic effect to oxycodone by "static" and "dynamic" quantitative sensory testing in healthy subjects. Pain 2010, 151 (1), 104-9.
212. Tyce, G. M.; Yaksh, T. L. Monoamine release from cat spinal cord by somatic stimuli: An intrinsic modulatory system. J. Physiol. 1981, 314, 513-29.
213. Weil-Fugazza, J.; Godefroy, F.; Chitour, D.; Le Bars, D. Synthesis of serotonin at the spinal level in the rat: modifications induced by nociceptive somatic stimulation associated or not with administration of morphine. C. R. Seances Acad. Sci., Ser. III 1981, 293 (1), 89-91.
214. Kraus, E.; Besson, J. M.; Le Bars, D. Behavioral model for diffuse noxious inhibitory controls (DNIC): potentiation by 5-hydroxytryptophan. Brain Res. 1982, 231 (2), 461-5.
215. Carstens, E.; Fraunhoffer, M.; Zimmermann, M. Serotonergic mediation of descending inhibition from midbrain periaqueductal gray, but not reticular formation, or spinal nociceptive transmission in the cat. Pain 1981, 10 (2), 149-67.
216. Engberg, I.; Lundberg, A.; Ryall, R. W. Is the tonic decerebrate inhibition of reflex paths mediated by monoaminergic pathways? Acta Physiol. Scand. 1968, 72 (1), 123-33.
217. Griersmith, B. T.; Duggan, A. W.; North, R. A. Methysergide and supraspinal inhibition of the spinal transmission of nociceptive information in the anaesthetized cat. Brain Res. 1981, 204 (1), 147-58.
218. Yezierski, R. P.; Bowker, R. M.; Kevetter, G. A.; Westlund, K. N.; Coulter, J. D.; Willis, W. D. Serotonergic projections to the caudal brain stem: A double label study using horseradish peroxidase and serotonin immunocytochemistry. Brain Res. 1982, 239 (1), 258-64.
219. Yezierski, R. P.; Wilcox, T. K.; Willis, W. D. The effects of serotonin antagonists on the inhibition of primate spinothalamic tract cells produced by stimulation in nucleus raphe magnus or periaqueductal gray. J. Pharmacol. Exp. Ther. 1982, 220 (2), 266-77.
220. Rivot, J. P.; Calvino, B.; Besson, J. M. Is there a serotonergic tonic descending inhibition on the responses of dorsal horn convergent neurons to C-fibre inputs? Brain Res. 1987, 403 (1), 142-6.
221. Iyengar, S.; Webster, A. A.; Hemrick-Luecke, S. K.; Xu, J. Y.; Simmons, R. M. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 2004, 311 (2), 576-84.
222. Smith, T.; Nicholson, R. A. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc. Health Risk Manage. 2007, 3 (6), 833-44.
223. Anderberg, U. M.; Marteinsdottir, I.; von Knorring, L. Citalopram in patients with fibromyalgia-a randomized, double-blind, placebo-controlled study. Eur. J. Pain 2000, 4 (1), 27-35.
224. Arnold, L. M.; Hess, E. V.; Hudson, J. I.; Welge, J. A.; Berno, S. E.; Keck, P. E., Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am. J. Med. 2002, 112 (3), 191-7.
225. Wolfe, F.; Cathey, M. A.; Hawley, D. J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand. J. Rheumatol. 1994, 23 (5), 255-9.
226. Wright, A.; Luedtke, K. E.; Vandenberg, C. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy. J. Pain Res. 2011, 4, 1-10.
227. Pae, C. U.; Marks, D. C.; Han, C.; Patkar, A. A.; Masand, P. S. Duloxetine: An emerging evidence for fibromyalgia. Biomed. Pharmacother. 2009, 63 (1), 69-71.
228. Bazzichi, L.; Giannaccini, G.; Betti, L.; Mascia, G.; Fabbrini, L.; Italiani, P.; De Feo, F.; Giuliano, T.; Giacomelli, C.; Rossi, A.; et al. Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res. Ther. 2006, 8 (4), R99.
229. Legangneux, E.; Mora, J. J.; Spreux-Varoquaux, O.; Thorin, I.; Herrou, M.; Alvado, G.; Gomeni, C. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford) 2001, 40 (3), 290-6.
230. Wolfe, F.; Russell, I. J.; Vipraio, G.; Ross, K.; Anderson, J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J. Rheumatol. 1997, 24 (3), 555-9.
231. Yunus, M. B.; Dailey, J. W.; Aldag, J. C.; Masi, A. T.; Jobe, P. C. Plasma and urinary catecholamines in primary fibromyalgia: A controlled study. J. Rheumatol. 1992, 19 (1), 95-7.
232. Yunus, M. B.; Dailey, J. W.; Aldag, J. C.; Masi, A. T.; Jobe, P. C. Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J. Rheumatol. 1992, 19 (1), 90-4.
233. Treister, R.; Pud, D.; Ebstein, R. P.; Laiba, E.; Raz, Y.; Gershon, E.; Haddad, M.; Eisenberg, E. Association between polymorphisms in serotonin and dopamine-related genes and endogenous pain modulation. J. Pain 2011, 12 (8), 875-83.
234. Lindstedt, F.; Berrebi, J.; Greayer, E.; Lonsdorf, T. B.; Schalling, M.; Ingvar, M.; Ingvar, M.; Kosek, E. Conditioned pain modulation is associated with common polymorphisms in the serotonin transporter gene. PLoS One 2011, 6 (3), e18252.
235. Potvin, S.; Larouche, A.; Normand, E.; de Souza, J. B.; Gaumond, I.; Marchand, S.; Grignon, S. No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur. J. Pain 2010, 14 (7), 742-6.
236. Bardin, L.; Colpaert, F. C. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats. Eur. J. Pain 2004, 8 (3), 253-61.
237. Millan, M. J.; Seguin, L.; Honore, P.; Girardon, S.; Bervoets, K. Pro-and antinociceptive actions of serotonin (5-HT)1A agonists and antagonists in rodents: relationship to algesiometric paradigm. Behav. Brain Res. 1996, 73 (1-2), 69-77.
238. Kayser, V.; Elfassi, I. E.; Aubel, B.; Melfort, M.; Julius, D.; Gingrich, J. A.; Hamon, M.; Bourgoin, S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/-and 5-HTT-/-knock-out male mice. Pain 2007, 130 (3), 235-48.
239. Vera-Portocarrero, L. P.; Zhang, E. T.; King, T.; Ossipov, M. H.; Vanderah, T. W.; Lai, J.; Porreca, F. Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain 2007, 129 (1-2), 35-45.
240. Liang, D. Y.; Li, X.; Clark, J. D. 5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. Anesthesiology 2011, 114 (5), 1180-9.
241. Heinl, C.; Drdla-Schutting, R.; Xanthos, D. N.; Sandkuhler, J. Distinct mechanisms underlying pronociceptive effects of opioids. J. Neurosci. 2011, 31 (46), 16748-56.
242. Wen, Y. R.; Wang, C. C.; Yeh, G. C.; Hsu, S. F.; Huang, Y. J.; Li, Y. L.; SUn, W. Z. DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptors. J. Biomed. Sci. 2010, 17 (1), 19.
243. Sanada, T.; Kohase, H.; Makino, K.; Umino, M. Effects of alpha-adrenergic agonists on pain modulation in diffuse noxious inhibitory control. J. Med. Dent. Sci. 2009, 56 (1), 17-24.
244. Baba, Y.; Kohase, H.; Oono, Y.; Fujii-Abe, K.; Arendt-Nielsen, L. Effects of dexmedetomidine on conditioned pain modulation in humans. Eur. J. Pain 2012, 16 (8), 1137-47.
245. Makino, K.; Kohase, H.; Sanada, T.; Umino, M. Phenylephrine suppresses the pain modulation of diffuse noxious inhibitory control in rats. Anesth. Analg. 2010, 110 (4), 1215-21.
246. Kunz, M.; Scholl, K. E.; Schu, U.; Lautenbacher, S. GABAergic modulation of diffuse noxious inhibitory controls (DNIC): A test by use of lorazepam. Exp. Brain Res. 2006, 175 (2), 363-71.
247. Arendt-Nielsen, L.; Mansikka, H.; Staahl, C.; Rees, H.; Tan, K.; Smart, T. S.; Monhemius, R.; Suzuki, R.; Drewes, A. M. A translational study of the effects of ketamine and pregabalin on temporal summation of experimental pain. Reg. Anesth. Pain Med. 2011, 36 (6), 585-91.
248. Lee, J. H.; Cho, S. H.; Kim, S. H.; Chae, W. S.; Jin, H. C.; Lee, J. S.; Kim, Y. I. The effect of target-controlled infusion of low-dose ketamine on heat pain and temporal summation threshold. J. Anesth. 2011, 25 (4), 516-22.
249. Sher, G. D.; Mitchell, D. Intrathecal N-methyl-D-aspartate induces hyperexcitability in rat dorsal horn convergent neurones. Neurosci. Lett. 1990, 119 (2), 199-202.
250. Niesters, M.; Dahan, A.; Swartjes, M.; Noppers, I.; Fillingim, R. B.; Aarts, L.; Sarton, E. Y. Effect of ketamine on endogenous pain modulation in healthy volunteers. Pain 2011, 152 (3), 656-63.
251. Zhao, Y.; Wu, N.; Chen, S.; Boulanger, L.; Police, R. L.; Fraser, K. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies. Curr. Med. Res. Opin. 2010, 26 (9), 2147-56.
252. Chen, S.; Wu, N.; Fraser, K.; Boulanger, L.; Zhao, Y. Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments. Curr. Med. Res. Opin. 2010, 26 (10), 2507-16.
253. Celerier, E.; Gonzalez, J. R.; Maldonado, R.; Cabanero, D.; Puig, M. M. Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology 2006, 104 (3), 546-55.
254. DuPen, A.; Shen, D.; Ersek, M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manage. Nurs. 2007, 8 (3), 113-21.
255. Zhao, M.; Joo, D. T. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology 2008, 109 (2), 308-17.
256. Lee, M.; Silverman, S. M.; Hansen, H.; Patel, V. B.; Manchikanti, L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011, 14 (2), 145-61.
257. Sikka, P.; Kaushik, S.; Kumar, G.; Kapoor, S.; Bindra, V. K.; Saxena, K. K. Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice. J. Pharm. Bioallied Sci. 2011, 3 (3), 412-6.
258. Ozdemir, E.; Gursoy, S.; Bagcivan, I. The effects of serotonin/ norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats. J. Physiol. Sci. 2012, 62 (4), 317-23.
259. Miyazaki, R.; Yamamoto, T. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model. Anesth. Analg. 2012, 115 (1), 182-8.
260. Ho, K. Y.; Tay, W.; Yeo, M. C.; Liu, H.; Yeo, S. J.; Chia, S. L.; Lo, N. N. Duloxetine reduces morphine requirements after knee replacement surgery. Br. J. Anaesth. 2010, 105 (3), 371-6.
261. Amr, Y. M.; Yousef, A. A. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin. J. Pain 2010, 26 (5), 381-5.
262. Bouwense, S. A.; Olesen, S. S.; Drewes, A. M.; Poley, J. W.; van Goor, H.; Wilder-Smith, O. H. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial. PLoS One 2012, 7 (8), e42096.
263. Pachman, D. R.; Barton, D. L.; Watson, J. C.; Loprinzi, C. L. Chemotherapyinduced peripheral neuropathy: prevention and treatment. Clin. Pharmacol. Ther. 2011, 90 (3), 377-87.
264. Yang, Y. H.; Lin, J. K.; Chen, W. S.; Lin, T. C.; Yang, S. H.; Jiang, J. K.; Chang, S. C.; Lan, Y. T.; Lin, C. C.; Yen, C. C.; et al. Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: An openlabel pilot study. Support Care Cancer 2012, 20 (7), 1491-7.
265. Hardy, J.; Agar, M. R.; Currow, D. C. Progressing an evidence-base beyond case series. J. Palliat. Med. 2011, 14 (12), 1283.
266. McQuay, H. J.; Moore, R. A. Antidepressants and chronic pain. BMJ 1997, 314 (7083), 763-4.
267. Kunz, R.; Oxman, A. D. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998, 317 (7167), 1185-90.
268. Hardy, J.; Quinn, S.; Fazekas, B.; Plummer, J.; Eckermann, S.; Agar, M.; Spruyt, O.; Rowett, D.; Currow, D. C. Randomized, double-blind, placebocontrolled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J. Clin. Oncol. 2012, 30 (29), 3611-7.